Down syndrome people have even lower D levels if have additional Vitamin D diseases
Hypovitaminosis D in persons with Down syndrome and autism spectrum disorder
J Neurodev Disord . 2023 Oct 25;15(1):35. doi: 10.1186/s11689-023-09503-y.
Natalie K Boyd 1, Julia Nguyen 2, Mellad M Khoshnood 1, Timothy Jiang 1, Lina Nguyen 1, Lorena Mendez 1, Noemi A Spinazzi 3, Melanie A Manning 4, Michael S Rafii 5 6, Jonathan D Santoro 7 8
Background: Plasma levels of vitamin D have been reported to be low in persons with Down syndrome (DS) and existing data is limited to small and homogenous cohorts. This is of particular importance in persons with DS given the high rates of autoimmune disease in this population and the known relationship between vitamin D and immune function. This study sought to investigate vitamin D status in a multi-center cohort of individuals with DS and compare them to individuals with autism spectrum disorder (ASD) and neurotypical (NT) controls.
Methods: A retrospective, multi-center review was performed. The three sites were located at latitudes of 42.361145, 37.44466, and 34.05349. Patients were identified by the International Classification of Diseases (ICD)-9 or ICD-10 codes for DS, ASD, or well-child check visits for NT individuals. The first vitamin D 25-OH level recorded in the electronic medical record (EMR) was used in this study as it was felt to be the most reflective of a natural and non-supplemented state. Vitamin D 25-OH levels below 30 ng/mL were considered deficient.
Results: In total, 1624 individuals with DS, 5208 with ASD, and 30,775 NT controls were identified.
Individuals with DS had the lowest mean level of vitamin D 25-OH at 20.67 ng/mL,
compared to those with ASD (23.48 ng/mL) and
NT controls (29.20 ng/mL) (p < 0.001, 95% CI: -8.97 to -6.44).
A total of 399 (24.6%) individuals with DS were considered vitamin D deficient compared to 1472 (28.3%) with ASD and 12,397 (40.3%) NT controls (p < 0.001, 95% CI: -5.43 to -2.36). Individuals with DS with higher body mass index (BMI) were found to be more likely to have lower levels of vitamin D (p < 0.001, 95% CI: -0.3849 to -0.1509).
Additionally, having both DS and a neurologic diagnosis increased the likelihood of having lower vitamin D levels (p < 0.001, 95% CI: -5.02 to -1.28).
Individuals with DS and autoimmune disease were much more likely to have lower vitamin D levels (p < 0.001, 95% CI: -6.22 to -1.55).
Similarly, a history of autoimmunity in a first-degree relative also increased the likelihood of having lower levels of vitamin D in persons with DS (p = 0.01, 95% CI: -2.45 to -0.63).
Conclusions: Individuals with DS were noted to have hypovitaminosis D in comparison to individuals with ASD and NT controls. Associations between vitamin D deficiency and high BMI, personal autoimmunity, and familial autoimmunity were present in individuals with DS.
📄 Download the PDF from VitaminDWiki
60 References
de Graaf G, Buckley F, Skotko BG. Estimates of the live births, natural losses, and elective terminations with Down syndrome in the United States. Am J Med Genet A. 2015;167a(4):756–67. - PubMed - DOI
de Graaf G, Buckley F, Skotko BG. Live births, natural losses, and elective terminations with Down syndrome in Massachusetts. Genet Med. 2016;18(5):459–66. - PubMed - DOI
Chicoine B, Rivelli A, Fitzpatrick V, Chicoine L, Jia G, Rzhetsky A. Prevalence of common disease conditions in a large cohort of individuals with Down syndrome in the United States. J Patient Cent Res Rev. 2021;8(2):86–97. - PubMed - PMC - DOI
Startin CM, D’Souza H, Ball G, Hamburg S, Hithersay R, Hughes KMO, et al. Health comorbidities and cognitive abilities across the lifespan in Down syndrome. J Neurodev Disord. 2020;12(1):4. - PubMed - PMC - DOI
Stagi S, Lapi E, Romano S, Bargiacchi S, Brambilla A, Giglio S, et al. Determinants of vitamin D levels in children and adolescents with Down syndrome. Int J Endocrinol. 2015;2015:896758. - PubMed - PMC - DOI
Real de Asua D, Quero M, Moldenhauer F, Suarez C. Clinical profile and main comorbidities of Spanish adults with Down syndrome. Eur J Intern Med. 2015;26(6):385–91. - PubMed - DOI
Zubillaga P, Garrido A, Mugica I, Ansa J, Zabalza R, Emparanza JI. Effect of vitamin D and calcium supplementation on bone turnover in institutionalized adults with Down ’s syndrome. Eur J Clin Nutr. 2006;60(5):605–9. - PubMed - DOI
Nodehi M, Ajami A, Izad M, Asgarian Omran H, Chahardoli R, Amouzegar A, et al. Effects of vitamin D supplements on frequency of CD4(+) T-cell subsets in women with Hashimoto’s thyroiditis: a double-blind placebo-controlled study. Eur J Clin Nutr. 2019;73(9):1236–43. - PubMed - DOI
Zhao R, Zhang W, Ma C, Zhao Y, Xiong R, Wang H, et al. Immunomodulatory function of vitamin D and its role in autoimmune thyroid disease. Front Immunol. 2021;12:574967. - PubMed - PMC - DOI
Ashtari F, Toghianifar N, Zarkesh-Esfahani SH, Mansourian M. Short-term effect of high-dose vitamin D on the level of interleukin 10 in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial. Neuroimmunomodulation. 2015;22(6):400–4. - PubMed - DOI
Hahn J, Cook NR, Alexander EK, Friedman S, Walter J, Bubes V, et al. Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ. 2022;376:e066452. - PubMed - PMC - DOI
Altun H, Kurutaş EB, Şahin N, Güngör O, Fındıklı E. The levels of vitamin D, vitamin D receptor, homocysteine and complex B vitamin in children with Autism spectrum disorders. Clin Psychopharmacol Neurosci. 2018;16(4):383–90. - PubMed - PMC - DOI
Molloy CA, Kalkwarf HJ, Manning-Courtney P, Mills JL, Hediger ML. Plasma 25(OH)D concentration in children with Autism spectrum disorder. Dev Med Child Neurol. 2010;52(10):969–71. - PubMed - PMC - DOI
Esnafoglu E, Subaşı B. Association of low 25-OH-vitamin D levels and peripheral inflammatory markers in patients with Autism spectrum disorder: vitamin D and inflammation in Autism . Psychiatry Res. 2022;316:114735. - PubMed - DOI
Zhang M, Wu Y, Lu Z, Song M, Huang X, Mi L, et al. Effects of vitamin D supplementation on children with Autism spectrum disorder: a systematic review and meta-analysis. Clin Psychopharmacol Neurosci. 2023;21(2):240–51. - PubMed - PMC - DOI
Li B, Xu Y, Zhang X, Zhang L, Wu Y, Wang X, et al. The effect of vitamin D supplementation in treatment of children with Autism spectrum disorder: a systematic review and meta-analysis of randomized controlled trials. Nutr Neurosci. 2022;25(4):835–45. - PubMed - DOI
Wagner CL, Greer FR. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics. 2008;122(5):1142–52. - PubMed - DOI
Petruzzelli MG, Marzulli L, Margari F, De Giacomo A, Gabellone A, Giannico OV, et al. Vitamin D deficiency in Autism spectrum disorder: a cross-sectional study. Dis Markers. 2020;2020:9292560. - PubMed - PMC - DOI
Şengenç E, Kıykım E, Saltik S. Vitamin D levels in children and adolescents with Autism . J Int Med Res. 2020;48(7):300060520934638. - PubMed - DOI
Arastoo AA, Khojastehkia H, Rahimi Z, Khafaie MA, Hosseini SA, Mansouri MT, et al. Evaluation of serum 25-hydroxy vitamin D levels in children with Autism spectrum disorder. Ital J Pediatr. 2018;44(1):150. - PubMed - PMC - DOI
Corder JP, Al Ahbabi FJS, Al Dhaheri HS, Chedid F. Demographics and co-occurring conditions in a clinic-based cohort with Down syndrome in the United Arab Emirates. Am J Med Genet A. 2017;173(9):2395–407. - PubMed - DOI
Santoro JD, Partridge R, Tanna R, Pagarkar D, Khoshnood M, Rehmani M, et al. Evidence of neuroinflammation and immunotherapy responsiveness in individuals with Down syndrome regression disorder. J Neurodev Disord. 2022;14(1):35. - PubMed - PMC - DOI
Santoro SL, Baumer NT, Cornacchia M, Franklin C, Hart SJ, Haugen K, et al. Unexplained regression in Down syndrome: management of 51 patients in an international patient database. Am J Med Genet A. 2022;188(10):3049–62.
Santoro SL, Cannon S, Capone G, Franklin C, Hart SJ, Hobensack V, et al. Unexplained regression in Down syndrome: 35 cases from an international Down syndrome database. Genet Med. 2020;22(4):767–76. - PubMed - DOI
Santoro JD, Lee S, Wang AC, Ho E, Nagesh D, Khoshnood M, et al. Increased autoimmunity in individuals with Down syndrome and moyamoya disease. Front Neurol. 2021;12:724969. - PubMed - PMC - DOI
Goksin S. Retrospective evaluation of clinical profile and comorbidities in patients with alopecia areata. North Clin Istanb. 2022;9(5):451–8. - PubMed - PMC
Sassi F, Tamone C, D’Amelio P. Vitamin D: nutrient, hormone, and immunomodulator. Nutrients. 2018;10(11):1656. https://pubmed.ncbi.nlm.nih.gov/30400332/
Vanherwegen AS, Gysemans C, Mathieu C. Regulation of immune function by vitamin D and its use in diseases of immunity. Endocrinol Metab Clin North Am. 2017;46(4):1061–94. - PubMed - DOI
Prietl B, Treiber G, Mader JK, Hoeller E, Wolf M, Pilz S, et al. High-dose cholecalciferol supplementation significantly increases peripheral CD4+ Tregs in healthy adults without negatively affecting the frequency of other immune cells. Eur J Nutr. 2014;53(3):751–9. - PubMed - DOI
Bock G, Prietl B, Mader JK, Höller E, Wolf M, Pilz S, et al. The effect of vitamin D supplementation on peripheral regulatory T cells and β cell function in healthy humans: a randomized controlled trial. Diabetes Metab Res Rev. 2011;27(8):942–5. - PubMed - DOI
Treiber G, Prietl B, Fröhlich-Reiterer E, Lechner E, Ribitsch A, Fritsch M, et al. Cholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset type 1 diabetes mellitus - a randomized clinical trial. Clin Immunol. 2015;161(2):217–24. - PubMed - DOI
Cao B, Wen T, Wei M, Xiong Y, Liu W, Zhu L, et al. Transcriptomic analysis reveal the responses of dendritic cells to VDBP. Genes Genomics. 2022;44(10):1271–82. - PubMed - DOI
Navarro-Barriuso J, Mansilla MJ, Quirant-Sánchez B, Teniente-Serra A, Ramo-Tello C, MartÃnez-Cáceres EM. Vitamin D3-induced tolerogenic dendritic cells modulate the transcriptomic profile of T CD4(+) cells towards a functional hyporesponsiveness. Front Immunol. 2020;11:599623. - PubMed - DOI
Bernicke B, Engelbogen N, Klein K, Franzenburg J, Borzikowsky C, Peters C, et al. Analysis of the seasonal fluctuation of γδ T cells and its potential relation with vitamin D(3). Cells. 2022;11(9).
Sheikh V, Kasapoglu P, Zamani A, Basiri Z, Tahamoli-Roudsari A, Alahgholi-Hajibehzad M. Vitamin D3 inhibits the proliferation of T helper cells, Down regulate CD4(+) T cell cytokines and upregulate inhibitory markers. Hum Immunol. 2018;79(6):439–45. - PubMed - DOI
Siracusano M, Riccioni A, Abate R, Benvenuto A, Curatolo P, Mazzone L. Vitamin D deficiency and Autism spectrum disorder. Curr Pharm Des. 2020;26(21):2460–74. - PubMed - DOI
Galoppin M, Kari S, Soldati S, Pal A, Rival M, Engelhardt B, et al. Full spectrum of vitamin D immunomodulation in multiple sclerosis: mechanisms and therapeutic implications. Brain Commun. 2022;4(4):fcac171. - PubMed - PMC - DOI
Antico A, Tampoia M, Tozzoli R, Bizzaro N. Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun Rev. 2012;12(2):127–36. - PubMed - DOI
Agmon-Levin N, Theodor E, Segal RM, Shoenfeld Y. Vitamin D in systemic and organ-specific autoimmune diseases. Clin Rev Allergy Immunol. 2013;45(2):256–66. - PubMed - DOI
Spinazzi NA, Santoro JD, Pawlowski K, Anzueto G, Howe YJ, Patel LR, et al. Co-occurring conditions in children with Down syndrome and Autism : a retrospective study. J Neurodev Disord. 2023;15(1):9. - PubMed - PMC - DOI
Ferrari M, Stagi S. Autoimmunity and genetic syndromes: a focus on Down syndrome. Genes (Basel). 2021;12(2).
Taksler GB, Cutler DM, Giovannucci E, Keating NL. Vitamin D deficiency in minority populations. Public Health Nutr. 2015;18(3):379–91. - PubMed - DOI
Kumaratne M, Early G, Cisneros J. Vitamin D deficiency and association with body mass index and lipid levels in Hispanic American adolescents. Glob Pediatr Health. 2017;4:2333794x17744141. - PubMed - PMC
Talib HJ, Ponnapakkam T, Gensure R, Cohen HW, Coupey SM. Treatment of vitamin D deficiency in predominantly Hispanic and Black adolescents: a randomized clinical trial. J Pediatr. 2016;170:266-72.e1. - PubMed - DOI
Muscogiuri G, Barrea L, Somma CD, Laudisio D, Salzano C, Pugliese G, et al. Sex differences of vitamin D status across BMI classes: an observational prospective cohort study. Nutrients. 2019;11(12).
Oreskovic NM, Baumer NT, Di Camillo C, Cornachia M, Franklin C, Hart SJ, et al. Cardiometabolic profiles in children and adults with overweight and obesity and Down syndrome. Am J Med Genet A. 2023;191(3):813–22. - PubMed - DOI
Bandini LG, Fleming RK, Scampini R, Gleason J, Must A. Is body mass index a useful measure of excess body fatness in adolescents and young adults with Down syndrome? J Intellect Disabil Res. 2013;57(11):1050–7. - PubMed - DOI
De Pergola G, Martino T, Zupo R, Caccavo D, Pecorella C, Paradiso S, et al. 25 Hydroxyvitamin D levels are negatively and independently associated with fat mass in a cohort of healthy overweight and obese subjects. Endocr Metab Immune Disord Drug Targets. 2019;19(6):838–44. - PubMed - PMC - DOI
Heller JE, Thomas JJ, Hollis BW, Larson-Meyer DE. Relation between vitamin D status and body composition in collegiate athletes. Int J Sport Nutr Exerc Metab. 2015;25(2):128–35. - PubMed - DOI
Ross CF, Bernhard CB, Smith-Simpson S. Parent-reported ease of eating foods of different textures in young children with Down syndrome. J Texture Stud. 2019;50(5):426–33. - PubMed - DOI
Serel Arslan S. Swallowing related problems of toddlers with Down syndrome. J Dev Phys Disabil. 2022:1–11. https://pubmed.ncbi.nlm.nih.gov/36118664/ .
Ross CF, Bernhard CB, Surette V, Hasted A, Wakeling I, Smith-Simpson S. Eating behaviors in children with Down syndrome: results of a home-use test. J Texture Stud. 2022;53(5):629–46. - PubMed - DOI
Song L, Luo X, Jiang Q, Chen Z, Zhou L, Wang D, et al. Vitamin D supplementation is beneficial for children with Autism spectrum disorder: a meta-analysis. Clin Psychopharmacol Neurosci. 2020;18(2):203–13. - PubMed - PMC - DOI
Feng J, Shan L, Du L, Wang B, Li H, Wang W, et al. Clinical improvement following vitamin D3 supplementation in Autism spectrum disorder. Nutr Neurosci. 2017;20(5):284–90. - PubMed - DOI
Saad K, Abdel-Rahman AA, Elserogy YM, Al-Atram AA, Cannell JJ, Bjørklund G, et al. Vitamin D status in Autism spectrum disorders and the efficacy of vitamin D supplementation in autistic children. Nutr Neurosci. 2016;19(8):346–51. - PubMed - DOI
Kerley CP, Power C, Gallagher L, Coghlan D. Lack of effect of vitamin D(3) supplementation in Autism : a 20-week, placebo-controlled RCT. Arch Dis Child. 2017;102(11):1030–6. - PubMed - DOI
Sullivan KD, Evans D, Pandey A, Hraha TH, Smith KP, Markham N, et al. Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation. Sci Rep. 2017;7(1):14818. - PubMed - PMC - DOI
Hisbiyah Y, Endaryanto A, Setyoboedi B, Rochmah N, Faizi M. The correlation between vitamin D and levels of IFN-γ, NF-κB, thyroid antibodies in Down syndrome: study in Indonesian children. Acta Biomed. 2022;93(6):e2022342. - PubMed - PMC
Ragab D, Soliman D, Samaha D, Yassin A. Vitamin D status and its modulatory effect on interferon gamma and interleukin-10 production by peripheral blood mononuclear cells in culture. Cytokine. 2016;85:5–10. - PubMed - DOI
Izquierdo-Gomez R, MartÃnez-Gómez D, Acha A, Veiga OL, Villagra A, Diaz-Cueto M. Objective assessment of sedentary time and physical activity throughout the week in adolescents with Down syndrome The UP&Down; study. Res Dev Disabil. 2014;35(2):482–9. - PubMed - DOI
Esposito PE, MacDonald M, Hornyak JE, Ulrich DA. Physical activity patterns of youth with Down syndrome. Intellect Dev Disabil. 2012;50(2):109–19. - PubMed - DOI
VitaminDWiki - Down's syndrome and low vitamin D - several studies
VitaminDWiki – Autism category contains:
{include}
VitaminDWiki – Autoimmune category contains:
{include}